Trial
NCT02068079
A Pilot Study of Trientine With Vemurafenib for the Treatment BRAF Mutated Metastatic Melanoma
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Duke University
Collaborators
—
Condition
Melanoma
Intervention
Vemurafenib and Trientine
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-01-30